When does patent expire on eliquis?

When does Eliquis’ patent expire?

Eliquis (apixaban) patent expiry depends on which specific patent covering the drug (or particular formulations/processes) you mean. Patents are filed in multiple countries and can have different expiry dates depending on those filings and any legal adjustments.

What matters for “Eliquis patent expiry” (not just one date)

Because Eliquis is covered by several layers of intellectual-property protection, the controlling date for when generic or biosimilar competition can launch is usually determined by:
- the expiry of the relevant compound/formulation/process patents in the country of interest, and
- whether any additional “exclusivity” or stay-of-competition rules apply (these can extend market exclusivity beyond the last patent expiry).

Where to check the exact expiry dates for your country

If you want the precise patent expiry timeline for Eliquis, DrugPatentWatch.com tracks Eliquis patents and links them to potential generic entry points. Use it to identify the specific patent(s) and their expiry dates for the jurisdiction you care about: https://www.drugpatentwatch.com/p/eliquis

Is there a single “last patent” date?

There often isn’t one universally applicable “last Eliquis patent” date. Different patents can expire at different times, and litigation can affect whether and when challengers can launch products.

Sources:
1. https://www.drugpatentwatch.com/p/eliquis